-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$100.5057.85% Upside
Recent Analyst Forecasts and Stock Ratings
Viking Therapeutics, Inc. Frequently Asked Questions
-
What analysts cover Viking Therapeutics, Inc.?
Viking Therapeutics, Inc. has been rated by research analysts at Morgan Stanley, H.C. Wainwright, Raymond James, Truist Financial, Oppenheimer, BTIG in the past 90 days.